Boehringer Ingelheim Extends Use of Medidata Rave


Medidata and Boehringer Ingelheim announced a five-year renewal of their collaboration in the area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata.

Read more about the collaboration here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.